See also our related blogs for the Keller Laboratory and the Pediatric Preclinical Testing Initiative.

Thursday, June 16, 2011

Wilm's Tumor Clinical Scientist, Dr. Douglas Weeks

Pediatric embryonal tumors of the kidney often have very good outcomes, yet stratification to a particular treatment regimen depends to the great extent on the careful eye of a specialized pathologist. At OHSU, Department of Pathology Chairman, Dr. Douglas Weeks, is one such key Wilms tumor pathology expert.  Having such a pioneer and active participant of the National Wilms Tumor Study Group at OHSU is of enormous value to the study of this childhood cancer -- and other tumors of embryonic origin.  

No comments:

Post a Comment